| Literature DB >> 27330378 |
Palaniselvam Kuppusamy1, Mashitah M Yusoff1, Gaanty Pragas Maniam1, Natanamurugaraj Govindan1.
Abstract
The field of nanotechnology mainly encompasses with biology, physics, chemistry and material sciences and it develops novel therapeutic nanosized materials for biomedical and pharmaceutical applications. The biological syntheses of nanoparticles are being carried out by different macro-microscopic organisms such as plant, bacteria, fungi, seaweeds and microalgae. The biosynthesized nanomaterials have been effectively controlling the various endemic diseases with less adverse effect. Plant contains abundant natural compounds such as alkaloids, flavonoids, saponins, steroids, tannins and other nutritional compounds. These natural products are derived from various parts of plant such as leaves, stems, roots shoots, flowers, barks, and seeds. Recently, many studies have proved that the plant extracts act as a potential precursor for the synthesis of nanomaterial in non-hazardous ways. Since the plant extract contains various secondary metabolites, it acts as reducing and stabilizing agents for the bioreduction reaction to synthesized novel metallic nanoparticles. The non-biological methods (chemical and physical) are used in the synthesis of nanoparticles, which has a serious hazardous and high toxicity for living organisms. In addition, the biological synthesis of metallic nanoparticles is inexpensive, single step and eco-friendly methods. The plants are used successfully in the synthesis of various greener nanoparticles such as cobalt, copper, silver, gold, palladium, platinum, zinc oxide and magnetite. Also, the plant mediated nanoparticles are potential remedy for various diseases such as malaria, cancer, HIV, hepatitis and other acute diseases.Entities:
Keywords: Biological synthesis; Chronic diseases; Metallic nanoparticles; Plants; Secondary metabolites
Year: 2014 PMID: 27330378 PMCID: PMC4908060 DOI: 10.1016/j.jsps.2014.11.013
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Figure 1Different types of nanoparticle synthesis from plant resources.
Figure 2Proposed mechanism of nanoparticle synthesis using plant extracts.
Figure 3Different size and shapes of the nanoparticle synthesis from plant extracts (derived from Chandran et al., 2006, Dubey et al., 2010).
Summary of plant derived metallic nanoparticles and its biomedical applications.
| Plants used | Nanoparticles | Parts of plant | Size (nm) | Shapes | Plant metabolites involved in bioreduction | Pharmacological applications | Cited |
|---|---|---|---|---|---|---|---|
| Ag, Au | Leaves | 20–30 | Spherical | Quercetin, plant pigment | Antibacterial | ||
| In2O3 | Leaf | 5–50 | Spherical | Biomolecules | Optical properties | ||
| Ag | Whole | 40 | Spherical | Amine, carboxyl group | Antioxidant, antimicrobial | ||
| Ag | Leaves | 67–88 | Spherical | Alkaloids, flavonoids | Hepatocurative activity | ||
| Ag | Leaves | 20–50 | Spherical | Protein, | Antimicrobial | ||
| Ag | Leaves | 70–90 | Spherical | Secondary metabolites | Antimicrobial | Song et al. (2009) | |
| Ag | Gum | 7–10 | Spherical | Protein, enzyme | Antibacterial | ||
| Ag | Fruit | 15 | Spherical | Hydroxyl flavones, catechins | Antimicrobial | ||
| Au | Stem | 55–98 | Spherical | Hydroxyl group | Antihypoglycemic | Daisy et al. (2012) | |
| Ag | Leaves | 45 | Spherical | Water soluble organics | Antibacterial | ||
| Ag | Calli | 5–70 | Triangle | Polyphenols | Antioxidant, anticancer | ||
| Ag | Peel | 35 | Spherical | Water soluble compounds | Antibacterial | ||
| Ag | Fruit | 11–24 | Spherical | Biomolecules | Antibacterial | ||
| Ag | Tuber | 8–20 | Rod, triangular | Diosgenin, ascorbic acid | Antimicrobial | ||
| Ag | Leaves | 52 | Rod, spherical | Protein, polyphenols | Antiplasmodial | ||
| Ag | whole | 112 | Spherical | Protein, amide, amine group | Cytotoxicity | ||
| Ag | Leaves | 15–30 | Spherical, | Isoverbascoside compound | Antimicrobial | ||
| Au, Ag | Leaves | 90–150 | Spherical | Menthol | Antibacterial | ||
| Au | Flowers | ∼100 | Spherical | Polysaccharides | Antimicrobial | Vankar et al. (2010) | |
| Ag | Whole | 113 | Spherical | Phenolics, protein | Cytotoxicity | ||
| Ag | Leaves | 44–64 | Cubic | Biomolecules phenolic compound | Biological activities | Dipankar et al. (2012) | |
| Ag | Leaves | 78 | Irregular | Tannic acid, polyphenols | Cytotoxicity | ||
| Ag | Leaves | 34 | Spherical | Phenolic compound | Antilarvicidal | ||
| Au | Seed | 15–25 | Spherical | Flavonoids | Catalytic | Aromal et al. (2012) | |
| Ag | Leaves | 5–40 | Irregular, spherical | Methyl 7-oxooctadecanoate | Antimicrobial |
Figure 4(a–c) Examples of different secondary metabolites are synthesized metallic nanoparticles.